Epicresearch
Asha Soni
Ranbaxy Laboratories’ (RLL) wholly owned subsidiary – Ranbaxy Pharmaceuticals Inc (RPI) has launched the authorized generic cevimeline hydrochloride 30 mg capsules in the US market, under an agreement with Daiichi Sankyo, Inc.
MCX tips| Commodity tips
MCX tips| Commodity tips